# AbbVie Inc. – Consensus ‘buy’ rating and 17.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/abbvie-inc-consensus-buy-rating-and-17-3-upside-potential/4121184020
- Published: 2025-01-17T15:18:20+00:00
- Author: Charlotte Edwards

**AbbVie Inc.** with ticker code (ABBV) now have 27 analysts in total covering the
stock. The consensus rating is pointing to ‘buy’. The range between the high target
price and low target price is between $225.00 and $165.00 calculating the mean target
price we have $201.01. Given that the stocks previous close was at $171.35 this 
would imply there is now a potential upside of 17.3%. The 50 day moving average 
now sits at $178.01 and the 200 day moving average is $178.69. The company has a
market cap of 306.95B. The current share price for the company is: $173.70 USD

 The potential market cap would be $360,078,443,282 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 60.52, revenue per share of $31.40
and a 7.72% return on assets.

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. 
The Company is engaged in the research and development, manufacturing, commercialization
and sale of medicines and therapies. It offers products in various therapeutic categories,
including immunology products, which include Humira, Skyrizi and Rinvoq; oncology
products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that
include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience
products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye
care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis,
and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella
and Synthroid. Its products are sold to wholesalers, distributors, government agencies,
health care facilities, specialty pharmacies, and independent retailers from the
AbbVie-owned distribution centers and public warehouses.

Share on: